z-logo
Premium
Inter‐relationship of fat‐soluble vitamins in progression of renal calcification
Author(s) -
Fu Xueyan,
Mernitz Heather,
Wallin Reidar,
Wang XiangDong,
Booth Sarah L
Publication year - 2008
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.22.1_supplement.1106.8
Subject(s) - calcification , endocrinology , chemistry , medicine , matrix gla protein , vitamin , kidney , carcinogenesis , biochemistry , ectopic calcification , cancer
Both 1alpha, 25 dihydroxyvitamin D3 (1,25D, 5.0 μg/kg diet) and 9‐cis retinoic acid (9cRA, 15 mg/kg diet) inhibited lung carcinogenesis in a tobacco carcinogen (NNK)‐initiated A/J mouse model, but 9cRA mitigated 1,25D‐induced renal calcification (Mernitz et al, 2007). Matrix gamma‐carboxyglutamic acid protein (MGP) requires vitamin K for gamma‐carboxylation, which confers its function as an inhibitor of soft tissue calcification. We therefore hypothesized that fat‐soluble vitamins may regulate MGP expression and function. RT‐PCR (n=10 per group) and western blotting (n=3 per group) were used to assess MGP expression, and gamma‐carboxylation in kidneys of 4 groups of mice: Control (NNK alone), 1,25D (NNK+1,25D), 9cRA (NNK+9cRA) and COMBO (NNK+1,25D+9cRA). Kidney MGP mRNA levels were significantly higher (~two‐fold) in 1,25D group compared to all other groups (p<0.01). However, there were less carboxylated MGP levels (relative density) in the 1,25D group [1.8±1.1 vs. 4.6±0.8 (Control); 5.2±0.7 (9cRA); 6.5±3.2 (COMBO); p<0.05]. In contrast, tissue vitamin K levels (pmol/g) were lowest in the 9cRA and COMBO groups [67±32 (Control); 63±13 (1,25D); 18±7 (9cRA); 33±14 (COMBO); p<0.01]. Although the role of vitamin K in this process is unclear, these data suggest that 1,25D can induce renal calcification through the impaired carboxylation of MGP, whereas 9cRA protects against it.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here